SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-019117
Filing Date
2022-07-19
Accepted
2022-07-19 17:33:18
Documents
1
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165826637954909.html 3  
1 FORM 3 wf-form3_165826637954909.xml 3 1691
  Complete submission text file 0001628280-22-019117.txt   3039
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Habig Scott Michael (Reporting) CIK: 0001938159 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 221092326